✦ LIBER ✦

Ornithine transcarbamylase deficiency: Pathogenesis of the cerebral disorder and new prospects for therapy

✍ Scribed by Adrianna Michalak; Roger F. Butterworth

Book ID: 110613893
Publisher: Springer
Year: 1997
Tongue: English
Weight: 756 KB
Volume: 12
Category: Article
ISSN: 0885-7490
DOI: 10.1007/bf02674610

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achievement of successful pregnancy in t

Achievement of successful pregnancy in the preimplantation genetic diagnosis for Duchenne Muscular Dystrophy (DMD), Ornithine Transcarbamylase (OTC) deficiency, and Epidermolysis Bullosa (EB) of single gene disorders

✍ Hyoung-Song Lee; Hye Won Choi; Jin Hyun Jun; Chun Kyu Lim; Mi Kyung Koong; Inn S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 44 KB

H intragenic polymorphisms and haplotype

H intragenic polymorphisms and haplotype analysis in the ornithine transcarbamylase (OTC) gene and their relevance for tracking the inheritance of OTC deficiency

✍ Consuelo Climent; Vicente Rubio 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 1 views

The "private" nature of most mutations causing ornithine transcarbamylase (OTC) deficiency makes mutation identification in the patients difficult. Further, the PCR-amplification technology generally used for the genetic diagnosis of the deficiency misses large deletions in carrier females. Intragen

Female heterozygotes for the hypomorphic

Female heterozygotes for the hypomorphic R40H mutation can have ornithine transcarbamylase deficiency and present in early adolescence: a case report and review of the literature

✍ Jason R Pinner, Mary-Louise Freckmann, Edwin P Kirk… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 274 KB

The prospect of molecular therapy for An

The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders

✍ Barbara J Bailus,David J Segal 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 281 KB

Prospects and challenges for the develop

Prospects and challenges for the development of new therapies for Ewing sarcoma

✍ Grohar, Patrick J.; Helman, Lee J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 631 KB

Identification of a cytogenetic deletion

Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency

✍ Consuelo Climent; Miguel Ángel García-Pérez; Pablo Sanjurjo; José-Ignacio Ruiz-S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 16 KB 👁 3 views

A deletion of at least 11.5 cM in the paternal X chromosome mapping between microsatellites DXS989 and DXS1003 and encompassing the genes for ornithine transcarbamylase (OTC), retinitis pigmentosa GTPase regulator (RPGR) and dystrophin, was associated with the loss of band Xp21 in a female patient w